Who has invested in ProQR Therapeutics?

No investors are named on the public record for ProQR Therapeutics yet.

ProQR Therapeutics Funding: $300M Raised, IPO

ProQR Therapeutics funding overview

ProQR Therapeutics is based in Leiden, Netherlands. ProQR Therapeutics has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO.

ProQR Therapeutics at a glance

Total raised: $300M
Latest round: IPO
Headquarters: Leiden, Netherlands

Frequently asked about ProQR Therapeutics funding

How much has ProQR Therapeutics raised?: ProQR Therapeutics has raised $300M in total disclosed funding across the rounds on record.
Who has invested in ProQR Therapeutics?: No investors are named on the public record for ProQR Therapeutics yet.
What was the latest ProQR Therapeutics funding round?: The most recent disclosed round is an IPO.
Where is ProQR Therapeutics based?: ProQR Therapeutics is based in Leiden, Netherlands.

We update the ProQR Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Leiden and their backers are listed below.

ProQR Therapeutics Funding: $300M Raised, IPO

ProQR Therapeutics funding overview

ProQR Therapeutics at a glance

Frequently asked about ProQR Therapeutics funding

Companies related to ProQR Therapeutics (38)

Browse related funding lists (2)